glp-1 agonist benefits Drugs & What They Do Potential Kidney Benefits of GLP-1

For more information about Keystone Infectious Diseases, click here.

Mean weight loss induced by semaglutide and tirzepatide in obese but nondiabetic individuals

Racial and ethnic disparities are evident, with Asian, Black, and Hispanic patients less likely to receive these medications compared to White patients, partly due to structural racism and socioeconomic factors

Various CVOT trials, such as the SELECT, SUSTAIN, and SOUL trials, have demonstrated varying effects on heart diseases over the years [13,39,46]

Second, T2DM patients who received various GLP-1 receptor agonist drugs, such as albiglutide, exenatide, liraglutide, semaglutide, lixisenatide and dulaglutide might have biased the meta-analysis results